Design-Elememt

Biotech Report 2015


Titelbild (© vfa bio)

A brief summary of the key economic data in medical biotechnology in Germany, a ten-year comparison and seven assumptions on developments, which are likely to shape the biopharmaceutical industry over the course of the next ten years.
read on

BIOTECH-REPORT 2014

Medical biotechnology in Germany 2014 – Biopharmaceuticals: Economic data and benefit for patients with rare diseases


The new biotech report describing the situation of medical biotechnology in Germany is now available. It was provided by The Boston Consulting Group for vfa bio. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies.
read on

Biotech Report 2013

Biopharmaceuticals: Economic data and benefit for patients in the process of demographic change


The new biotech report describing the situation of medical biotechnology in Germany is now available. It was provided by The Boston Consulting Group for vfa bio. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies.
read on

Biotech Report 2012

Medical Biotechnology in Germany 2012 – Biopharmaceuticals: Economic data and new application areas with benefit for patients


The new vfa bio report “Medical Biotechnology in Germany 2012 – Biopharmaceuticals: Economic data and new application areas with benefit for patients” is now available. It was provided by The Boston Consulting Group. This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies.
read on